Nasopharyngeal Bacterial Microbiota Composition and SARS-CoV-2 IgG Antibody Maintenance in Asymptomatic/Paucisymptomatic Subjects
SARS-CoV-2
Microbiota
immunoglobulins
COVID-19
Antibodies, Viral
UNICORN
Microbiology
QR1-502
Cellular and Infection Microbiology
Immunoglobulin G
Nasopharynx
SARS-CoV-2; UNICORN; asymptomatic carriers; immunoglobulins; nasopharyngeal bacterial microbiota
nasopharyngeal bacterial microbiota
Humans
RNA, Viral
asymptomatic carriers
SARS-CoV-2; UNICORN; asymptomatic carriers; immunoglobulins; nasopharyngeal bacterial microbiota; Antibodies, Viral; Humans; Immunoglobulin G; Nasopharynx; RNA, Viral; SARS-CoV-2; COVID-19; Microbiota
DOI:
10.3389/fcimb.2022.882302
Publication Date:
2022-07-07T09:08:35Z
AUTHORS (10)
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the disease 2019 (COVID-19), ranging from asymptomatic conditions to severe/fatal lung injury and multi-organ failure. Growing evidence shows that nasopharyngeal microbiota composition may predict severity of infections play a role in protection viral entry regulation immune response infection. In present study, we have characterized bacterial (BNM) performed factor analysis group 54 asymptomatic/paucisymptomatic subjects who tested positive for swab SARS-CoV-2 RNA and/or showed anti-RBD-IgG serology at enrolment. We investigated whether BNM was associated with positivity serum antibody development/maintenance 20–28 weeks after Shannon’s entropy α-diversity index [odds ratio (OR) = 5.75, p 0.0107] Factor1 (OR 2.64, 0.0370) were positively maintenance. results suggest influence immunological memory against infections. To best our knowledge, this is first study investigating link between specific IgG Further studies are needed unveil mechanisms through which influences adaptive
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....